Tempest Therapeutics, Inc. Estimated Litigation Liability, Current
Tempest Therapeutics, Inc. (TPST) had Estimated Litigation Liability, Current of $450.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LitigationReserveCurrent · last filed 2024-03-19
- 2023-03-31: Estimated Litigation Liability, Current $450.00K.
- 2022-12-31: Estimated Litigation Liability, Current $450.00K.
- 2022-09-30: Estimated Litigation Liability, Current $15.20M.
- 2022-06-30: Estimated Litigation Liability, Current $15.00M.
| Period end | Estimated Litigation Liability, Current |
|---|---|
| 2023-03-31 | $450.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $450.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $15.20M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $15.00M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $15.00M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $15.00M 10-K · filed 2023-03-22 |
| 2021-03-31 | $15.00M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |